AU2015329581B2 - Compositions comprising amino acids for use in the treatment of stroke in patients with dysphagia - Google Patents

Compositions comprising amino acids for use in the treatment of stroke in patients with dysphagia Download PDF

Info

Publication number
AU2015329581B2
AU2015329581B2 AU2015329581A AU2015329581A AU2015329581B2 AU 2015329581 B2 AU2015329581 B2 AU 2015329581B2 AU 2015329581 A AU2015329581 A AU 2015329581A AU 2015329581 A AU2015329581 A AU 2015329581A AU 2015329581 B2 AU2015329581 B2 AU 2015329581B2
Authority
AU
Australia
Prior art keywords
composition
active agent
leucine
patients
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2015329581A
Other languages
English (en)
Other versions
AU2015329581A1 (en
Inventor
Paolo Luca Maria Giorgetti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Professional Dietetics SpA
Original Assignee
Professional Dietetics SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Professional Dietetics SpA filed Critical Professional Dietetics SpA
Publication of AU2015329581A1 publication Critical patent/AU2015329581A1/en
Application granted granted Critical
Publication of AU2015329581B2 publication Critical patent/AU2015329581B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2015329581A 2014-10-08 2015-10-07 Compositions comprising amino acids for use in the treatment of stroke in patients with dysphagia Ceased AU2015329581B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITTO20140806 2014-10-08
ITTO2014A000806 2014-10-08
PCT/IB2015/057662 WO2016055948A1 (en) 2014-10-08 2015-10-07 Compositions comprising amino acids for use in the treatment of stroke in patients with dysphagia

Publications (2)

Publication Number Publication Date
AU2015329581A1 AU2015329581A1 (en) 2017-03-02
AU2015329581B2 true AU2015329581B2 (en) 2019-02-07

Family

ID=52101507

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015329581A Ceased AU2015329581B2 (en) 2014-10-08 2015-10-07 Compositions comprising amino acids for use in the treatment of stroke in patients with dysphagia

Country Status (14)

Country Link
US (1) US9707198B2 (enExample)
EP (1) EP3006027B1 (enExample)
JP (1) JP6447716B2 (enExample)
KR (1) KR102077374B1 (enExample)
AU (1) AU2015329581B2 (enExample)
CA (1) CA2958033C (enExample)
DK (1) DK3006027T3 (enExample)
ES (1) ES2651903T3 (enExample)
HU (1) HUE035699T2 (enExample)
NO (1) NO3006027T3 (enExample)
NZ (1) NZ728962A (enExample)
PL (1) PL3006027T3 (enExample)
RU (1) RU2668373C1 (enExample)
WO (1) WO2016055948A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016181335A1 (en) * 2015-05-14 2016-11-17 Professional Dietetics S.P.A. Compositions comprising amino acids for use in the treatment of mucositides in neoplasia patients undergoing radiation therapy and/or chemotherapy
IT201700087376A1 (it) * 2017-07-28 2019-01-28 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012142678A1 (en) * 2011-04-21 2012-10-26 Fit-Bioceuticals Limited Weight loss composition
WO2014065715A1 (en) * 2012-10-24 2014-05-01 Solovyev Nikolay Vladimirovich Composition for parenteral administration, method for producing and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4780475A (en) * 1986-02-03 1988-10-25 Cerra Frank B Preparation for the prevention of catabolism
US5276018A (en) * 1992-07-17 1994-01-04 Brigham And Women's Hospital Composition comprising amino acids and methods for decreasing muscle breakdown
IT1320783B1 (it) * 2000-07-04 2003-12-10 Professional Dietetics Srl Composizioni a base di aminoacidi, atte al miglioramento delleprestazioni muscolari.
US20030060421A1 (en) * 2001-07-19 2003-03-27 Neuron Therapeutics, Inc. Kits and compositions supporting intracranial perfusions
EP2275084A1 (en) * 2009-07-15 2011-01-19 Unilever PLC Oral care composition
EP3231435A1 (en) * 2009-07-20 2017-10-18 Nestec S.A. Methods of attenuating the loss of functional status
BR112013022060B1 (pt) * 2011-03-01 2019-11-26 Nestec Sa produto nutricional, métodos para sua preparação e para melhorar sua coesão, e usos de um polímero de grau alimentício
JP2012214451A (ja) * 2011-03-25 2012-11-08 En Otsuka Pharmaceutical Co Ltd 炎症性疾患用アミノ酸組成物
JP5837315B2 (ja) * 2011-03-25 2015-12-24 イーエヌ大塚製薬株式会社 炎症性疾患用栄養組成物
WO2012133198A1 (ja) * 2011-03-25 2012-10-04 イーエヌ大塚製薬株式会社 炎症性疾患用栄養組成物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012142678A1 (en) * 2011-04-21 2012-10-26 Fit-Bioceuticals Limited Weight loss composition
WO2014065715A1 (en) * 2012-10-24 2014-05-01 Solovyev Nikolay Vladimirovich Composition for parenteral administration, method for producing and use thereof

Also Published As

Publication number Publication date
KR20170057308A (ko) 2017-05-24
DK3006027T3 (en) 2017-12-18
US9707198B2 (en) 2017-07-18
CA2958033A1 (en) 2016-04-14
HUE035699T2 (en) 2018-05-28
ES2651903T3 (es) 2018-01-30
WO2016055948A1 (en) 2016-04-14
KR102077374B1 (ko) 2020-02-13
CA2958033C (en) 2019-07-16
JP2017530103A (ja) 2017-10-12
EP3006027B1 (en) 2017-11-15
NO3006027T3 (enExample) 2018-04-14
EP3006027A1 (en) 2016-04-13
NZ728962A (en) 2019-05-31
AU2015329581A1 (en) 2017-03-02
US20160101078A1 (en) 2016-04-14
PL3006027T3 (pl) 2018-02-28
RU2668373C1 (ru) 2018-09-28
JP6447716B2 (ja) 2019-01-09

Similar Documents

Publication Publication Date Title
Bo et al. A high whey protein, vitamin D and E supplement preserves muscle mass, strength, and quality of life in sarcopenic older adults: A double-blind randomized controlled trial
Børsheim et al. Effect of amino acid supplementation on muscle mass, strength and physical function in elderly
JP5550002B2 (ja) 高齢者の骨格筋量減少を防止又は改善するためのアミノ酸含有組成物
WO2011075741A1 (en) Improved method of administering beta-hydroxy-beta-methylbutyrate (hmb)
Aquilani et al. Unaffected arm muscle hypercatabolism in dysphagic subacute stroke patients: the effects of essential amino acid supplementation
Lee et al. Enhancement of Lower Limb Muscle Strength and Reduction of Inflammation in the Elderly: A Randomized, Double-Blind Clinical Trial Comparing Lacticaseibacillus paracasei PS23 Probiotic with Heat-Treated Supplementation
AU2015329581B2 (en) Compositions comprising amino acids for use in the treatment of stroke in patients with dysphagia
CN108371326B (zh) 一种降血糖的功能性组合物
JP2016210720A (ja) 運動機能改善剤、呼吸機能改善剤または認知能改善剤
US20230131476A1 (en) Compositions containing amino acids and methods of using such compositions for treating sarcopenia
Aluri et al. Glucocorticoids and cornstarch therapy for non–islet cell tumor hypoglycemia: a case report
Kawano et al. Successful treatment of heart failure in an adult patient with Prader-Willi syndrome
NL8104818A (nl) Geneesmiddel voor het behandelen van suikerziekte en werkwijze voor de toediening van het preparaat.
JP2023530485A (ja) 運動なしで、筋量、筋力および筋機能を改善するためのβ－ヒドロキシ－β－メチルブチレート（ＨＭＢ）の組成物および使用法
WO2018085440A1 (en) Reduction and prevention of muscle loss by conjugated linoleic acid (cla) and vitamin d
RU2113227C1 (ru) Способ лечения ожирения
Winkler et al. 19 Nutrition and the Geriatric Surgery Patient
EP1964558A1 (en) Pharmaceutical compositions containing intestinal lipase inhibiting substances combined with a chromium dinicotinate o-coordinated complex for use in the treatment and control of obesity and overweight
Baldissarro et al. Clinical Study The Hip Functional Retrieval after Elective Surgery May Be Enhanced by Supplemented Essential Amino Acids
Ross et al. 31 An Integrative Nutrition Approach to Eating Disorders

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired